Company Filing History:
Years Active: 1990-1992
Title: Jan M Balzarini: Innovator in Antiviral Therapeutics
Introduction
Jan M Balzarini is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of antiviral therapeutics, particularly in the treatment of human immunodeficiency virus (HIV). With a total of 2 patents, his work has the potential to impact the lives of many individuals affected by AIDS and related diseases.
Latest Patents
Balzarini's latest patents focus on the therapeutic application of the compound 2',3'-dideoxycytidinene. This compound has demonstrated an antiviral effect against HIV, making it a promising candidate for therapeutic use in treating AIDS and related diseases. The patents detail compositions containing this compound, emphasizing its potential as a therapeutic agent.
Career Highlights
Throughout his career, Balzarini has worked with various organizations, including Stichting Rega Vzw and the Government of the United States of America. His research and innovations have contributed to advancements in antiviral therapies, showcasing his dedication to improving public health.
Collaborations
Balzarini has collaborated with esteemed colleagues such as Erik D De Clercq and Piet A Herdewijn. These partnerships have further enriched his research and development efforts in the field of antiviral therapeutics.
Conclusion
Jan M Balzarini's work in antiviral therapeutics highlights his commitment to addressing critical health challenges. His innovative contributions continue to pave the way for advancements in the treatment of HIV and AIDS.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.